Selective Neuron Loss in the Paraventricular Nucleus of Hypothalamus in Patients Suffering from Major Depression and Bipolar Disorder

The structural basis for depressive disorders remains unknown. Studies using neuroimaging and postmortem brain tissue indicate that anatomic substrates may contribute to major depression disorder (MDD) and bipolar disorder (BD). The present study used design-based stereology to assess neuron loss in 2 well-defined hypothalamic structures, the paraventricular nucleus (PVN) and supraoptic nucleus (SON), in clinically well-studied cases with severe depression. The left or right diencephalon was blocked from 26 brains removed at autopsy from age-matched controls (5 male/3 female) and patients with MDD (6 male/5 female) and BD (5 male/2 female). Serial sections were cut at an instrument setting of 60 μm through the entire PVN and SON from left hypothalamus and 8 to 10 sections per brain were systematic-random sampled and stained with cresyl violet. A trained operator blind to clinical diagnosis used computerized stereology to estimate total neuron numbers in PVN and SON. The results revealed a selective, robust reduction of approximately 50% in total neuron number in the PVN for major depression and bipolar cases compared with age-matched controls, with no differences in neuron numbers in the SON. This selective neuronal loss in the PVN appears to identify an important neurobiologic substrate for the behavioral manifestations of depression.

[1]  R. Duman.  Depression: a case of neuronal life and death? , 2004, Biological Psychiatry.

[2]  K. Kovács,et al.  GABAergic Mechanisms Constraining the Activity of the Hypothalamo‐Pituitary‐Adrenocortical Axis , 2004, Annals of the New York Academy of Sciences.

[3]  N. Barden.  CRSN Symposium : Focus on Depression , Part I Symposium du CRSN : le point sur la dépression , première partie Implication of the hypothalamic – pituitary – adrenal axis in the physiopathology of depression , 2004 .

[4]  D. Muller,et al.  Local γ‐aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin‐releasing factor neuron activity in the paraventricular nucleus of the hypothalamus , 2004 .

[5]  D. Muller,et al.  Local gamma-aminobutyric acid and glutamate circuit control of hypophyseotrophic corticotropin-releasing factor neuron activity in the paraventricular nucleus of the hypothalamus. , 2004, The European journal of neuroscience.

[6]  F. Holsboer,et al.  Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin , 2004, Neuropsychopharmacology.

[7]  D. Ingram,et al.  Effects of estrogen and raloxifene on neuroglia number and morphology in the hippocampus of aged female mice , 2003, Neuroscience.

[8]  H. Kraemer,et al.  Untreated depression and hippocampal volume loss. , 2003, The American journal of psychiatry.

[9]  B. Bogerts,et al.  Further Immunohistochemical Evidence for Impaired NO Signaling in the Hypothalamus of Depressed Patients , 2002, Annals of the New York Academy of Sciences.

[10]  J. Price,et al.  Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.

[11]  Paul J. Harrison,et al.  The neuropathology of primary mood disorder. , 2002, Brain : a journal of neurology.

[12]  Peter R. Mouton,et al.  Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists , 2002 .

[13]  F. Benes,et al.  The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects , 2001, Biological Psychiatry.

[14]  U. Ehlert,et al.  Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus–pituitary–adrenal axis , 2001, Biological Psychology.

[15]  F. Holsboer,et al.  Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. , 2001, The American journal of pathology.

[16]  G. Rajkowska,et al.  Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells , 2000, Biological Psychiatry.

[17]  G. Rajkowska,et al.  Enhancement of Hippocampal Neurogenesis by Lithium , 2000, Journal of neurochemistry.

[18]  G Paxinos,et al.  Organization of the human paraventricular hypothalamic nucleus , 2000, The Journal of comparative neurology.

[19]  E. Fliers,et al.  Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression. , 2000, Progress in brain research.

[20]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[21]  D. German,et al.  Quantification of cholinergic and select non-cholinergic mesopontine neuronal populations in the human brain , 1999, Neuroscience.

[22]  J. Price,et al.  Prefrontal cortical projections to the hypothalamus in Macaque monkeys , 1998, The Journal of comparative neurology.

[23]  Yvette I. Sheline,et al.  Amygdala core nuclei volumes are decreased in recurrent major depression , 1998, Neuroreport.

[24]  H. Soya,et al.  Increased expression of magnocellular arginine vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats. , 1998, Life sciences.

[25]  B. Bogerts,et al.  Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics , 1998, Neuroscience.

[26]  D. Wied,et al.  The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. , 1998, Progress in brain research.

[27]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[28]  G. Christensen,et al.  Stereological MRI volumetry of the frontal lobe , 1996, Psychiatry Research: Neuroimaging.

[29]  D. Swaab,et al.  Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. , 1996, Archives of general psychiatry.

[30]  G. Halliday,et al.  Comparison of the Number of Vasopressin‐Producing Hypothalamic Neurons in Rats and Humans , 1995, Journal of neuroendocrinology.

[31]  D. Swaab,et al.  Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. , 1994, Neuroendocrinology.

[32]  Hans Jørgen G. Gundersen,et al.  Absolute number and size of pigmented locus coeruleus neurons in young and aged individuals , 1994, Journal of Chemical Neuroanatomy.

[33]  K. Krishnan,et al.  Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. , 1992, Archives of general psychiatry.

[34]  E. Fliers,et al.  The supraoptic and paraventricular nuclei of the human hypothalamus in relation to sex, age and Alzheimer's disease , 1990, Neurobiology of Aging.

[35]  R. Nieuwenhuys,et al.  Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease , 1990, Neuroscience Letters.

[36]  C. Coffey,et al.  Leukoencephalopathy in elderly depressed patients referred for ECT , 1988, Biological Psychiatry.

[37]  C. Nemeroff,et al.  Leukoencephalopathy in patients diagnosed as major depressive , 1988, Biological Psychiatry.

[38]  D. C. Sterio.  The unbiased estimation of number and sizes of arbitrary particles using the disector , 1984, Journal of microscopy.

[39]  L W Swanson,et al.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. , 1983, Annual review of neuroscience.

[40]  L. Swanson,et al.  Biological effects of cysteamine: relationship to somatostatin depletion , 1983, Regulatory Peptides.

[41]  Allan Morton.  A quantitative analysis of the normal neuron population of the hypothalamic magnocellular nuclei in man and of their projections to the neurohypophysis , 1969, The Journal of comparative neurology.